Related Experiment Video

Updated: Aug 26, 2026

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Antisense therapeutics and the treatment of CNS disease

Laura B Jaeger1, William A Banks

  • 1Saint Louis University School of Medicine, Department of Pharmacology and Physiology, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|February 24, 2004
PubMed

Insights

Antisense oligonucleotides (ONs) show promise for treating central nervous system (CNS) diseases by reducing target gene expression. This review explores ONs that can cross the blood-brain barrier (BBB) for effective CNS therapeutics.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Antisense oligonucleotides (ONs) offer precise, sequence-specific gene expression reduction for treating diseases caused by aberrant protein production.
  • Effective central nervous system (CNS) therapeutics require systemically administered ONs to cross the blood-brain barrier (BBB) efficiently.
  • The transport mechanisms of large, polar ONs across the BBB are not well understood, despite their therapeutic potential.

Purpose of the Study:

  • To review nucleic acid chemistries suitable for in vivo research involving antisense oligonucleotides (ONs).
  • To explore the potential applications of ONs in treating central nervous system (CNS) diseases.
  • To discuss the challenges and mechanisms of ONs crossing the blood-brain barrier (BBB).

Main Methods:

  • Literature review focusing on antisense oligonucleotide (ON) chemistry.
  • Analysis of studies investigating ON transport across the blood-brain barrier (BBB).
  • Examination of in vivo research and therapeutic applications for CNS diseases.

Main Results:

  • Antisense oligonucleotides (ONs) possess significant therapeutic potential for various pathologies.
  • ONs can cross the blood-brain barrier (BBB) without carrier systems, though mechanisms remain unclear.
  • Specific nucleic acid chemistries are being developed for effective in vivo research and CNS disease treatment.

Conclusions:

  • Antisense oligonucleotides (ONs) are promising for CNS disease treatment, contingent on effective BBB penetration.
  • Further research into the molecular mechanisms of ON transport across the BBB is crucial.
  • Optimized ON chemistries hold potential for advancing the treatment of neurological disorders.

More Related Videos

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...